Capstone Investment Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-600
Closed -$157K 1760
2024
Q4
$157K Sell
600
-1,000
-63% -$252K ﹤0.01% 1634
2024
Q3
$372K Buy
1,600
+200
+14% +$41.1K ﹤0.01% 1318
2024
Q2
$283K Hold
1,400
﹤0.01% 1609
2024
Q1
$240K Sell
1,400
-13,100
-90% -$2.44M ﹤0.01% 1936
2023
Q4
$3.15M Buy
14,500
+14,400
+14,400% +$2.47M 0.01% 669
2023
Q3
$15.9K Buy
+100
New +$22.4K ﹤0.01% 2063

Other funds holding PODD

Capstone Investment Advisors's PODD Position: Q1 2026 in Review

Capstone Investment Advisors increased its Insulet (PODD) stake by 58% in Q1 2026, buying an estimated $421K and bringing the position to 4,541 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Capstone Investment Advisors first reported a position in PODD in Q2 2014 and has held it in 10 quarters since. The position peaked at $1.19M in Q2 2014. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Capstone Investment Advisors held 4,541 shares of Insulet worth $953K as of Q1 2026.
  • Capstone Investment Advisors bought 1,676 Insulet shares in Q1 2026, an estimated $421K.
  • Insulet made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #878 holding.
  • Capstone Investment Advisors first reported a position in Insulet in Q2 2014 and has held it in 10 quarters since.
  • Capstone Investment Advisors's Insulet position peaked at $1.19M in Q2 2014.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.